Table of Contents


Abstract

Discontinuing Risperidone Linked to Agitation in Alzheimer's

Prenatal Antidepressant Exposure Not Linked to Intellectual, Behavioral Effects

Rhabdomyolysis Linked to Pregabalin and Simvastatin

Bipolar Patients at Higher Risk for Adverse Pregnancy Outcomes

FDA: Benefits of New Obesity Drugs Greater than Risks

Study Examines Risk for Cardiovascular Events of Varenicline vs. Bupropion

Scopolamine Augmentation for Moderate to Severe Depression

N-acetylcysteine as an Add-On Treatment for OCD

Memantine Augmentation for Moderate to Severe OCD

Discontinuation

Paxil Labeling Revision

Ancillary